<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

When a Clinical Trial Starts Slipping, Guesswork Is Not a Strategy

A practical triage framework to identify, prioritize, and fix the most common causes of delayed or at-risk ophthalmic endpoints before they derail your study.

Get the Free Playbook

The Clinical Trial Rescue Triage Playbook from 20/20 Onsite gives sponsors and CROs a clear, repeatable way to assess risk, take control, and stabilize execution when ocular endpoints are involved.

100% On-Time • 80% Less Patient Travel • 70% Fewer Dropouts

Trusted across 40+ trials, 85,000 exams, and leading partners.

20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Vertex
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Biogen
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Syneos
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients AGTC
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Blue Bird Bio

Instant PDF • 8–12 min read • No Spam

We’ll email the PDF and follow-up resources.
Unsubscribe anytime.

2020 Onsite Clinical Trial Rescue Triage Playbook

What This Playbook Helps You Do

  • Quickly diagnose where your trial is breaking down
    Not just that there is a problem, but why it is happening and what matters most right now.

    Separate noise from true risk
    Identify which issues threaten timelines, endpoints, or regulatory compliance and which ones are distractions.

    Make confident, defensible decisions under pressure
    Use a structured framework instead of reactive fixes or vendor patchwork.

    Stabilize execution without restarting the study
    Recover momentum without protocol overhauls or site churn.

Trusted by leading sponsors, CROs, and sites

Point of Need

100%

Screening timelines met across all business operations.

Data Integrity

98%

Data accuracy submission rate.

Patient Retention

91%

Patient retention rate vs industry standard 70%.

Patient Centricity

95+

Patient NPS score.

Why This Matters Now

Ocular risk is no longer limited to ophthalmology trials.

More sponsors are encountering ophthalmic endpoints as secondary safety measures, regulatory requirements, or post-market obligations, often without in-house expertise to manage them at scale.

When issues surface late, the cost is rarely linear.
Delays compound.
Dropouts increase.
Data quality erodes.

This playbook helps you intervene before small operational cracks become trial-level failures